BetterLife Pharma Inc.
BetterLife Pharma Inc. (“BetterLife”) is an emerging biotechnology company engaged in the development and commercialization of therapeutic pharmaceuticals as well as drug delivery platform technologies. Through its wholly owned subsidiary, BLife Therapeutics Inc., BetterLife is refining and developing drug candidates from a broad set of complementary Interferon-based technologies which have the potential to engage the immune system to fight virus infections, such as the coronavirus disease (COVID-19) and human papillomavirus (HPV), and/or to directly inhibit tumours to treat specific types of cancer.
BetterLife Pharma Inc. (BETR)
Le 31 aout/August 2020
Following a fundamental change review the common shares of BetterLife Pharma Inc. have requalified for listing.
Listing and disclosure documents will be available at www.thecse.com on the trading date.